| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4269290 | A | Drug level in human liver microsomes treated with BSA bound d6-alpha-tocopheryl quinone assessed as CYP4F2-mediated compound formation at 4.4 mM preincubated for 10 mins followed by NADPH addition measured after 20 mins by LS-MS analysis | Homo sapiens | 3 | microsome format | Scientific Literature | ||
| 2. | ALA4269292 | A | Drug level in human liver microsomes treated with BSA bound d6-alpha-tocopheryl quinone assessed as CYP4F2-mediated compound formation by measuring compound retention time at 4.4 mM preincubated for 10 mins followed by NADPH addition measured after 20 mins by LS-MS analysis | Homo sapiens | 4 | microsome format | Scientific Literature | ||
| 3. | ALA4269296 | A | Drug level assessed as recombinant human CYP4F2 expressed in insect cell microsomes-mediated compound formation treated with BSA bound d6-alpha-tocopheryl quinone at 10 uM preincubated for 10 mins followed by NADPH addition measured after 20 mins in presence of recombinant human CYP reductase and cytochrome b5 by LS-MS analysis | Homo sapiens | 2 | assay format | Scientific Literature | ||
| 4. | ALA4269297 | A | Drug level assessed as recombinant human CYP4F2 expressed in insect cell microsomes-mediated compound formation by measuring compound retention time treated with BSA bound d6-alpha-tocopheryl quinone at 10 uM preincubated for 10 mins followed by NADPH addition measured after 20 mins in presence of recombinant human CYP reductase and cytochrome b5 by LS-MS analysis | Homo sapiens | 2 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!